• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在控制特定生长速率下,生产 GM-CSF 的糖基工程毕赤酵母的分批补料发酵。

Fed-batch fermentation of GM-CSF-producing glycoengineered Pichia pastoris under controlled specific growth rate.

机构信息

Unit for Molecular Glycobiology, Department for Molecular Biomedical Research, VIB, Ghent, Belgium.

出版信息

Microb Cell Fact. 2010 Nov 23;9:93. doi: 10.1186/1475-2859-9-93.

DOI:10.1186/1475-2859-9-93
PMID:21092289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3004841/
Abstract

BACKGROUND

Yeast expression systems with altered N-glycosylation are now available to produce glycoproteins with homogenous, defined N-glycans. However, data on the behaviour of these strains in high cell density cultivation are scarce.

RESULTS

Here, we report on cultivations under controlled specific growth rate of a GlycoSwitch-Man5 Pichia pastoris strain producing Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) at high levels (hundreds of milligrams per liter). We demonstrate that homogenous Man5GlcNAc2 N-glycosylation of the secreted proteins is achieved at all specific growth rates tested.

CONCLUSIONS

Together, these data illustrate that the GlycoSwitch-Man5 P. pastoris is a robust production strain for homogenously N-glycosylated proteins.

摘要

背景

目前已有经过修饰的酵母表达系统可用于生产具有均一、定义明确的 N-聚糖的糖蛋白。然而,关于这些菌株在高密度培养中的行为的数据却很少。

结果

在这里,我们报告了在控制特定生长速率下,一株产生粒细胞-巨噬细胞集落刺激因子(GM-CSF)的 GlycoSwitch-Man5 毕赤酵母菌株的培养情况,该菌株的产量很高(每升数百毫克)。我们证明,在所有测试的特定生长速率下,分泌蛋白的均一 Man5GlcNAc2 N-糖基化都能实现。

结论

综上所述,这些数据表明 GlycoSwitch-Man5 毕赤酵母是一种生产均一 N-糖基化蛋白的稳健生产菌株。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eba/3004841/4431fc0bae1a/1475-2859-9-93-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eba/3004841/88f7fec88b14/1475-2859-9-93-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eba/3004841/c74d7f8ae8c6/1475-2859-9-93-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eba/3004841/002a75d243a9/1475-2859-9-93-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eba/3004841/85eca8ae66ac/1475-2859-9-93-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eba/3004841/cc0b42bbbb14/1475-2859-9-93-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eba/3004841/93aa747cf3a0/1475-2859-9-93-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eba/3004841/4431fc0bae1a/1475-2859-9-93-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eba/3004841/88f7fec88b14/1475-2859-9-93-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eba/3004841/c74d7f8ae8c6/1475-2859-9-93-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eba/3004841/002a75d243a9/1475-2859-9-93-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eba/3004841/85eca8ae66ac/1475-2859-9-93-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eba/3004841/cc0b42bbbb14/1475-2859-9-93-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eba/3004841/93aa747cf3a0/1475-2859-9-93-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eba/3004841/4431fc0bae1a/1475-2859-9-93-7.jpg

相似文献

1
Fed-batch fermentation of GM-CSF-producing glycoengineered Pichia pastoris under controlled specific growth rate.在控制特定生长速率下,生产 GM-CSF 的糖基工程毕赤酵母的分批补料发酵。
Microb Cell Fact. 2010 Nov 23;9:93. doi: 10.1186/1475-2859-9-93.
2
Pichia pastoris versus Saccharomyces cerevisiae: a case study on the recombinant production of human granulocyte-macrophage colony-stimulating factor.巴斯德毕赤酵母与酿酒酵母:关于重组生产人粒细胞巨噬细胞集落刺激因子的案例研究
BMC Res Notes. 2017 Apr 4;10(1):148. doi: 10.1186/s13104-017-2471-6.
3
Production and purification of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) from high cell density cultures of Pichia pastoris.利用巴斯德毕赤酵母高密度培养生产和纯化重组人粒细胞巨噬细胞集落刺激因子(GM-CSF)
Bioprocess Biosyst Eng. 2007 Sep;30(5):305-12. doi: 10.1007/s00449-007-0124-1. Epub 2007 Apr 24.
4
Process optimization of constitutive human granulocyte-macrophage colony-stimulating factor (hGM-CSF) expression in Pichia pastoris fed-batch culture.毕赤酵母分批补料培养中组成型人粒细胞巨噬细胞集落刺激因子(hGM-CSF)表达的工艺优化
Appl Microbiol Biotechnol. 2006 Feb;69(6):650-7. doi: 10.1007/s00253-005-0018-6. Epub 2005 Jun 28.
5
Optimization of a glycoengineered Pichia pastoris cultivation process for commercial antibody production.优化毕赤酵母糖基工程培养工艺用于商业化抗体生产。
Biotechnol Prog. 2011 Nov-Dec;27(6):1744-50. doi: 10.1002/btpr.695. Epub 2011 Oct 14.
6
Expression of recombinant human mast cell chymase with Asn-linked glycans in glycoengineered Pichia pastoris.在糖基工程毕赤酵母中表达具有天冬酰胺连接聚糖的重组人肥大细胞糜酶。
Protein Expr Purif. 2014 Oct;102:69-75. doi: 10.1016/j.pep.2014.08.005. Epub 2014 Aug 12.
7
Generation of diploid Pichia pastoris strains by mating and their application for recombinant protein production.通过交配生成二倍体巴斯德毕赤酵母菌株及其在重组蛋白生产中的应用。
Microb Cell Fact. 2012 Jul 2;11:91. doi: 10.1186/1475-2859-11-91.
8
[Pichia pastoris X-33 with OCH1 gene deletion and its expression of glycoprotein GM-CSF].[缺失OCH1基因的毕赤酵母X-33及其糖蛋白GM-CSF的表达]
Wei Sheng Wu Xue Bao. 2011 May;51(5):622-9.
9
[Construction of yeast Pichia pastoris to produce Man5GlcNAc2 mammalian mannose-type glycoprotein].[构建用于生产Man5GlcNAc2哺乳动物甘露糖型糖蛋白的巴斯德毕赤酵母]
Sheng Wu Gong Cheng Xue Bao. 2011 Jan;27(1):108-17.
10
Quantitative physiology of Pichia pastoris during glucose-limited high-cell density fed-batch cultivation for recombinant protein production.毕赤酵母在葡萄糖限制条件下进行高密度细胞补料分批发酵生产重组蛋白的定量生理学研究。
Biotechnol Bioeng. 2010 Oct 1;107(2):357-68. doi: 10.1002/bit.22836.

引用本文的文献

1
Homology-based identification and structural analysis of Annexins and Serine proteases to search molecules for wound healing applications.基于同源性的膜联蛋白和丝氨酸蛋白酶的鉴定与结构分析,以寻找用于伤口愈合应用的分子。
Comput Struct Biotechnol J. 2024 Oct 11;23:3680-3691. doi: 10.1016/j.csbj.2024.10.015. eCollection 2024 Dec.
2
Unveiling the potential of specific growth rate control in fed-batch fermentation: bridging the gap between product quantity and quality.揭示补料分批发酵中特定生长速率控制的潜力:弥合产物数量与质量之间的差距。
World J Microbiol Biotechnol. 2024 May 9;40(6):196. doi: 10.1007/s11274-024-03993-1.
3

本文引用的文献

1
N-glycosylation engineering of biopharmaceutical expression systems.生物制药表达系统的 N-糖基化工程。
Curr Mol Med. 2009 Sep;9(7):774-800. doi: 10.2174/156652409789105552.
2
Production of monoclonal antibodies by glycoengineered Pichia pastoris.通过糖基工程改造的巴斯德毕赤酵母生产单克隆抗体。
J Biotechnol. 2009 Feb 23;139(4):318-25. doi: 10.1016/j.jbiotec.2008.12.015. Epub 2008 Dec 27.
3
Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology.利用糖基开关技术在毕赤酵母中构建复杂型N-糖基化。
Current achievements, strategies, obstacles, and overcoming the challenges of the protein engineering in Pichia pastoris expression system.
毕赤酵母表达系统中蛋白质工程的当前成就、策略、障碍及挑战应对
World J Microbiol Biotechnol. 2023 Dec 8;40(1):39. doi: 10.1007/s11274-023-03851-6.
4
Overcoming Obstacles in Protein Expression in the Yeast Pichia pastoris: Interviews of Leaders in the Pichia Field.克服巴斯德毕赤酵母中蛋白质表达的障碍:巴斯德毕赤酵母领域领导者访谈
Pac J Health (Stockt). 2021;4(1). doi: 10.56031/2576-215x.1010.
5
Soluble Prokaryotic Overexpression and Purification of Human GM-CSF Using the Protein Disulfide Isomerase b'a' Domain.利用蛋白质二硫键异构酶b'a'结构域进行人GM-CSF的可溶性原核表达与纯化
Int J Mol Sci. 2021 May 17;22(10):5267. doi: 10.3390/ijms22105267.
6
Potential use of Pichia pastoris strain SMD1168H expressing DNA topoisomerase I in the screening of potential anti‑breast cancer agents.毕赤酵母表达 DNA 拓扑异构酶 I 的 SMD1168H 菌株在潜在抗乳腺癌药物筛选中的应用。
Mol Med Rep. 2019 Jun;19(6):5368-5376. doi: 10.3892/mmr.2019.10201. Epub 2019 Apr 30.
7
Production of a recombinant peroxidase in different glyco-engineered Pichia pastoris strains: a morphological and physiological comparison.不同糖基工程化毕赤酵母菌株中重组过氧化物酶的生产:形态学和生理学比较。
Microb Cell Fact. 2018 Nov 24;17(1):183. doi: 10.1186/s12934-018-1032-6.
8
Inactivation of a GAL4-like transcription factor improves cell fitness and product yield in glycoengineered Pichia pastoris strains.一种类GAL4转录因子的失活可提高糖基工程毕赤酵母菌株的细胞适应性和产物产量。
Appl Environ Microbiol. 2015 Jan;81(1):260-71. doi: 10.1128/AEM.02619-14. Epub 2014 Oct 24.
9
Expression of recombinant human mast cell chymase with Asn-linked glycans in glycoengineered Pichia pastoris.在糖基工程毕赤酵母中表达具有天冬酰胺连接聚糖的重组人肥大细胞糜酶。
Protein Expr Purif. 2014 Oct;102:69-75. doi: 10.1016/j.pep.2014.08.005. Epub 2014 Aug 12.
10
Determination of a dynamic feeding strategy for recombinant Pichia pastoris strains.重组毕赤酵母菌株动态补料策略的确定
Methods Mol Biol. 2014;1152:185-94. doi: 10.1007/978-1-4939-0563-8_11.
Nat Protoc. 2009;4(1):58-70. doi: 10.1038/nprot.2008.213.
4
Immunoblotting and immunodetection.免疫印迹法与免疫检测
Curr Protoc Immunol. 2001 May;Chapter 8:8.10.1-8.10.21. doi: 10.1002/0471142735.im0810s26.
5
One-dimensional SDS gel electrophoresis of proteins.蛋白质的一维十二烷基硫酸钠凝胶电泳
Curr Protoc Mol Biol. 2006 Aug;Chapter 10:Unit 10.2A. doi: 10.1002/0471142727.mb1002as75.
6
Rational design and optimization of fed-batch and continuous fermentations.补料分批发酵和连续发酵的合理设计与优化。
Methods Mol Biol. 2007;389:43-64. doi: 10.1007/978-1-59745-456-8_4.
7
Glycome mapping on DNA sequencing equipment.在DNA测序设备上进行糖组图谱分析。
Nat Protoc. 2006;1(1):397-405. doi: 10.1038/nprot.2006.60.
8
Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease.
J Mol Cell Cardiol. 2007 Jan;42(1):19-33. doi: 10.1016/j.yjmcc.2006.10.001. Epub 2006 Nov 15.
9
Humanization of yeast to produce complex terminally sialylated glycoproteins.酵母人源化以生产复杂的末端唾液酸化糖蛋白。
Science. 2006 Sep 8;313(5792):1441-3. doi: 10.1126/science.1130256.
10
Biopharmaceutical benchmarks 2006.2006年生物制药基准
Nat Biotechnol. 2006 Jul;24(7):769-76. doi: 10.1038/nbt0706-769.